Cardiovascular, endocrine, and renal effects of urodilatin in normal humans

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 276, Issue 3 45-3, 1999, Pages

  Bestle, Morten Heiberg ^a,b   Olsen, Niels Vidiendal ^b   Christensen, Poul ^a   Jensen, Benny Vittrup ^b   Bie, Peter ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Albuminuria; Atrial natriuretic factor; Cardiac output; Renal hemodynamics; Sodium excretion

Indexed keywords

ATRIAL NATRIURETIC FACTOR; URODILATIN;

ARTICLE; GLOMERULUS FILTRATION RATE; HEART OUTPUT; HUMAN; KIDNEY BLOOD FLOW; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEINURIA; SODIUM EXCRETION;

EID: 0032921379     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.276.3.r684     Document Type: Article

References (46)

1. Abassi, Z. A., J. Tate, S. Hunsberger, H. Klein, D. Trachewsky, and H. R. Keiser. Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition. Am. J. Physiol 263 (Endocrinol. Metab. 26): E870-E876, 1992.
2. Ando, S., T. Imaizumi, S. Harada, Y. Hirooka, and A. Takeshita. Atrial natriuretic peptide increases human capillary filtration and venous distensibility. J. Hypertens. 10: 451-457, 1992.
3. Atlas, S. A., and T. Maack. Atrial natriuretic factor. In: Handbook of Physiology. Renal Physiology. Bethesda, MD: Am. Physiol. Soc., 1992, sect. 8, vol. II, chapt. 33, p. 1577-1673.
4. Baum, M., and R. D. Toto. Lack of a direct effect of atrial natriuretic factor in the rabbit proximal tubule. Am. J. Physiol. 250 (Renal Fluid Electrolyte Physiol. 19): F66-F69, 1986.
5. Bergey, J. L., and D. Kotler. Effects of atriopeptins I, II and III on atrial contractility, sinus nodal rate (guinea pig) and agonist-induced tension in rabbit aortic strips. Eur. J. Pharmacol. 110: 277-281, 1985.
6. Bernstein, D. P. A new stroke volume equation for thoracic electrical bioimpedance: theory and rationale. Crit. Care Med. 14: 904-909, 1986.
7. Bestle, M. H., and P. Bie. Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs. Acta Physiol. Scand. 149: 77-83, 1993.
8. Biollaz, J., J. Nussberger, M. Porchet, F. Brunner Ferber, E. S. Otterbein, H. Gomez, B. Waeber, and H. R. Brunner. Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteers. Hypertension 8: II96-II105, 1986.
9. Bohm, M., F. Diet, B. Pieske, and E. Erdmann. h-ANF does not play a role in the regulation of myocardial force of contraction. Life Sci. 43: 1261-1267, 1988.
10. Bruun, N. E., P. Skott, and J. Giese. Renal and endocrine effects of physiological variations of atrial natriuretic factor in normal humans. Am. J. Physiol. 260 (Regulatory Integrative Comp. Physiol. 29): R217-R224, 1991.
11. Carstens, J., K. T. Jensen, P. Ivarsen, L. M. Rasmussen, and E. B. Pedersen. Development of a urodilatin-specific antibody and radioimmunoassay for urodilatin in human urine. Clin. Chem. 43: 638-643, 1997.
12. Carstens, J., K. T. Jensen, and E. B. Pedersen. Effect of urodilatin infusion on renal haemodynamics, tubular function and vasoactive hormones. Clin. Sci. Lond. 92: 397-407, 1997.
13. Cedidi, C., M. Meyer, E. R. Kuse, P. Schulz Knappe, B. Ringe, U. Frei, R. Pichlmayr, and W. G. Forssmann. Urodilatin: a new approach for the treatment of therapy-resistant acute renal failure after liver transplantation. Eur. J. Clin. Invest. 24: 632-639, 1994.
14. Chai, S. Y., P. M. Sexton, A. M. Allen, R. Figdor, and F. A. Mendelsohn. In vitro autoradiographic localization of ANP receptors in rat kidney and adrenal gland. Am. J. Physiol. 250 (Renal Fluid Electrolyte Physiol. 19): F753-F757, 1986.
15. Drummer, C., F. Fiedler, A. Bub, D. Kleefeld, E. Dimitriades, R. Gerzer, and W. G. Forssmann. Development and application of a urodilatin (CDD/ANP-95-126)-specific radioimmunoassay. Pflügers Arch. 423: 372-377, 1993.
16. Elsner, D., F. Muders, A. Muntze, E. P. Kromer, W. G. Forssmann, and G. A. Riegger. Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure. Am. Heart J. 129: 766-773, 1995.
17. Emmeluth, C., and P. Bie. Effects, release and disposal of endothelin-1 in conscious dogs. Acta Physiol. Scand. 146: 197-204, 1992.
18. +] during angiotensin II and aldosterone blockade. Acta Physiol. Scand. 151: 403-411, 1994.
19. Feldt Rasmussen, B., B. Dinesen, and M. Deckert. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand. J. Clin. Lab. Invest. 45: 539-544, 1985.
20. Feller, S. M., M. Gagelmann, and W. G. Forssmann. Urodilatin: a newly described member of the ANP family. Trends Pharmacol. Sci. 10: 93-94, 1989.
21. Floras, J. S. Sympathoinhibitory effects of atrial natriuretic factor in normal humans. Circulation 81: 1860-1873, 1990.
22. Gegelmann, M., D. Hock, and W. G. Forssmann. Urodilatin (CDD/ANP-95-126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (α-hANP/CDD-99-126). FEBS Lett. 233: 249-254, 1988.
23. Goetz, K. L. Renal natriuretic peptide (urodilatin?) and atriopeptin: evolving concepts. Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol. 30): F921-F932, 1991.
24. Hildebrandt, D. A., H. L. Mizelle, M. W. Brands, and J. E. Hall. Comparison of renal actions of urodilatin and atrial natriuretic peptide. Am. J. Physiol. 262 (Regulatory Integrative Comp. Physiol. 31): R395-R399, 1992.
25. Jamison, R. L., S. Canaan Kuhl, and R. Pratt. The natriuretic peptides and their receptors. Am. J. Kidney Dis. 20: 519-530, 1992.
26. Janssen, W. M., D. de Zeeuw, G. K. van der Hem, and P. E. de Jong. Atrial natriuretic peptide-induced decreases in renal blood flow in man: implications for the natriuretic mechanism. Clin. Sci. Lond. 77: 55-60, 1989.
27. Kaever, V., and K. Resch. Are cyclic nucleotides involved in the initiation of mitogenic activation of human lymphocytes? Biochim. Biophys. Acta 846: 216-225, 1985.
28. Kappelgaard, A. M., M. D. Nielsen, and J. Giese. Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clin. Chim. Acta 67: 299-306, 1976.
29. Kjaer, A., U. Knigge, A. Rouleau, M. Garbarg, and J. Warberg. Dehydration-induced release of vasopressin involves activation of hypothalamic histaminergic neurons. Endocrinology 135: 675-681, 1994.
30. Lee, M. E., T. N. Thrasher, and D. J. Ramsay. Mechanism of inhibition of renin secretion by increased left atrial pressure. Am. J. Physiol. 248 (Regulatory Integrative Comp. Physiol. 17): R641-R644, 1985.
31. Lee, R. W., R. G. Gay, and S. Goldman. Atrial natriuretic peptide reverses angiotensin-induced venoconstriction in dogs. Am. J. Physiol 257 (Heart Circ. Physiol. 26): H1062-H1067, 1989.
32. Marin Grez, M., J. T. Fleming, and M. Steinhausen. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature 324: 473-476, 1986.
33. 2-microglobulin excretion in man. J Hypertens. 6: 783-786, 1988.
34. Meyer, M., R. Richter, R. Brunkhorst, E. Wrenger, P. Schulz Knappe, A. Kist, P. Mentz, E. G. Brabant, K. M. Koch, G. Rechkemmer, and W. G. Forssmann. Urodilatin is involved in sodium homeostasis and exerts sodium state dependent natriuretic and diuretic effects. Am. J. Physiol. 271 (Renal Fluid Electrolyte Physiol. 40): F489-F497, 1996.
35. Renkin, E. M., and V. L. Tucker. Atrial natriuretic peptide as a regulator of transvascular fluid balance. News Physiol. Sci. 11: 138-143, 1996.
36. Ritter, D., P. Needleman, and J. E. Greenwald. Synthesis and secretion of an atriopeptin-like protein in rat kidney cell culture. J. Clin. Invest. 87: 208-212, 1991.
37. Saxenhofer, H., A. Raselli, P. Weidmann, W. G. Forssmann, A. Bub, P. Ferrari, and S. G. Shaw. Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men. Am. J. Physiol. 259 (Renal Fluid Electrolyte Physiol. 28): F832-F838, 1990.
38. Scheuer, D. A., T. N. Thrasher, L. C. Keil, and D. J. Ramsay. Mechanism of inhibition of renin response to hypotension by atrial natriuretic factor. Am. J. Physiol. 257 (Regulatory Integrative Comp. Physiol. 26): R194-R203, 1989.
39. Schulz-Knappe, P., K. Forssmann, F. Herbst, D. Hock, R. Pipkorn, and W. G. Forssmann. Isolation and structural analysis of "urodilatin," a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin. Wochenschr. 66: 752-759, 1988.
40. Schulz Knappe, P., U. Honrath, W. G. Forssmann, and H. Sonnenberg. Endogenous natriuretic peptides: effect on collecting duct function in rat kidney. Am. J. Physiol. 259 (Renal Fluid Electrolyte Physiol. 28): F415-F418, 1990.
41. Schutten, H. J., A. C. Johannessen, C. Torp-Pedersen, K. Sander-Jensen, P. Bie, and J. Warberg. Central venous pressure - a physiological stimulus for secretion of atrial natriuretic peptide in humans? Acta Physiol. Scand. 131: 265-272, 1987.
42. Singhal, P. C., S. DeCandido, J. A. Satriano, D. Schlondorff, and R. M. Hays. Atrial natriuretic peptide and nitroprusside cause relaxation of cultured rat mesangial cells. Am. J. Physiol. 257 (Cell Physiol. 26): C86-C93, 1989.
43. Thomsen, K., and D. G. Shirley. The validity of lithium clearance as an index of sodium and water delivery from the proximal tubules. Nephron 77: 125-138, 1997.
44. Valentin, J. P., L. A. Sechi, C. Qui, M. Schambelan, and M. H. Humphreys. Urodilatin binds to and activates renal receptors for atrial natriuretic peptide. Hypertension 21: 432-438, 1993.
45. Van Liew, J. B., W. Buentig, H. Stolte, and J. W. Boylan. Protein excretion: micropuncture study of rat capsular and proximal tubular fluid. Am. J. Physiol. 219: 299-305, 1970.
46. White, S. W., A. W. Quail, P. W. de Leeuw, F. M. Traugott, W. J. Brown, W. L. Porges, and D. B. Cottee. Impedance cardiography for cardiac output measurement: an evaluation of accuracy and limitations. Eur. Heart J. 11, Suppl. I: 79-92, 1990.